|
|
Journal of Cancer 2017
PART1 expression is associated with poor prognosis and tumor recurrence in stage I-III non-small cell lung cancerDOI: 10.7150/jca.18848 Keywords: non-small-cell lung carcinoma, lncRNAs, prostate androgen-regulated transcript-1, prognosis, biomarkers. Abstract: Purpose: Long noncoding RNAs (lncRNAs) have been demonstrated as effective markers for cancer detection and prognosis prediction. The aim of this study was to determine whether tissue PART1 could be used as a biomarker for prognosis prediction of non-small cell lung cancer (NSCLC).
|
